To the Editor A recent Research Letter provided evidence on high-engagement social media posts pertaining to pharmaceutical promotion. While the analysis addressed an important regulatory concern, several methodological issues may affect the interpretation of the study’s findings.
JAMA (Journal of the American Medical Association) published a clinical update in Research Highlights on 07 Apr 2026.
The item focuses on Social Media Posts Related to Prescription Drug Promotion.
Review the original article for the full source wording and details.